Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New phase II data for mipsagargin reported

Jan. 21, 2015

DT-01 enhances HCC treatment antitumor activity in animal models

Jan. 21, 2015

Active Biotech discusses pipeline outlook

Jan. 21, 2015

Researchers present data on the diagnostic utility of [11C]PBB-3-based PET imaging

Jan. 21, 2015

CEO presents development activity at BioMarin Pharmaceutical

Jan. 21, 2015

Alkermes presents overview of development pipeline at J.P. Morgan conference

Jan. 19, 2015

Ultragenyx Pharmaceuticals reviews pipeline

Jan. 19, 2015

Safety and dosing data presented for a novel gastric cancer vaccine

Jan. 19, 2015

Acorda Therapeutics provides overview on ongoing projects

Jan. 19, 2015

Phase I results presented for AMG-377 treatment of gastrointestinal tumors

Jan. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...